Master Sgt. Ron Bohl’s didn’t hesitate when he learned that his brother, Matthew, was battling stage 5 kidney disease, and ...

Another patient has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in ...

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...

Former University of Washington and NBA guard Nate Robinson is recovering after undergoing a successful kidney transplant ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...

A new study from Washington University in St. Louis has found that long-term use of popular heartburn medications may lead to serious kidney problems, including kidney failure. The drugs in question ...